Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 6, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Fuchs' Endothelial Dystrophy
Interventions
DRUG

Ripasudil hydrochloride hydrate 0.4% ophthalmic solution

"the ophthalmic solution will be administered three or six per times per day in the eye designated as the Study Eye upon study enrollment"

Trial Locations (1)

60026

RECRUITING

NorthShore University HealthSystem, Glenview

All Listed Sponsors
lead

Marian Macsai, MD

OTHER